Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002480 · ClinicalTrials.gov registry record · Phase 1
Radiation Therapy in Treating Patients With Prostate Cancer
A Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00002480: Completed Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00002480 is a Phase 1 study that has completed, run by Memorial Sloan Kettering Cancer Center. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002480, a Phase 1 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Radiation therapy may be an effective treatment for prostate cancer. PURPOSE: Phase I trial to study the effectiveness of radiation therapy in treating patients who have stage II or stage III prostate cancer.
Interventions
- RADIATION radiation therapy
Trial Details
| Field | Value |
|---|---|
| Start Date | 1991-02 |
| Est. Completion | 2005-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002480
The ClinicalTrials.gov registry entry for NCT00002480 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which radiation therapy is the first listed.
NCT00002480 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002480 about?
NCT00002480 is a clinical study titled "Radiation Therapy in Treating Patients With Prostate Cancer". RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Radiation therapy may be an effective treatment for prostate cancer. PURPOSE: Phase I trial to study the effectiveness of radiation therapy in treating patients who have stage II or stage III prostate cancer.
What is the current status of trial NCT00002480?
This trial is currently completed. It is a Phase 1 study. The study started on 1991-02. Estimated completion is 2005-08.
What interventions are being tested in trial NCT00002480?
The interventions under investigation include: radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT00002480?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.